Do you think CAPR will decline further?

**Capricor Therapeutics Inc (CAPR) is likely to experience continued pressure in the near term.** Here's a detailed analysis to support this view:

1. **Current Bearish Trend**: CAPR's stock is currently in a bearish trend with a 25-day duration. The probability of this trend continuing is 83%, with a clearer trend expected to persist for at least 24 days.
2. **Analyst Sentiment**: While analysts have set a high 12-month price target of $31.67, with a high estimate of $77.00, the current price at $16.84 reflects a significant gap to the average target. This suggests that analysts expect a potential upside, but the stock's recent performance does not yet align with these expectations.
|Ticker|Name|Date|Closing Price|code|market_code|
|---|---|---|---|---|---|
|CAPR.O|Capricor|20241203|16.84|CAPR|186|

3. **Market Reaction to News**: The recent decline of 14.26% in a single trading session indicates a strong negative reaction to recent news or events. Without positive catalysts, it's common for stocks to continue under pressure until there is a change in fundamentals or investor sentiment.
|Ticker|Name|Date|Closing Price|Trading Volume|code|market_code|
|---|---|---|---|---|---|---|
|CAPR.O|Capricor|20241203|16.84|2795988|CAPR|186|

4. **Financial Health Concerns**: Capricor has reported significant net losses in the recent quarters, with a trend of increasing losses over time. This financial health concerns could lead to further declines if not addressed.
|Ticker|Name|Date|Operating Income|Net Income|Diluted EPS|code|market_code|
|---|---|---|---|---|---|---|---|
|CAPR.O|Capricor|2023 Q4|-1281292|-762089||CAPR|186|
|CAPR.O|Capricor|2024 Q1|-1.0265902E7|-9794073|-0.31|CAPR|186|
|CAPR.O|Capricor|2024 Q2|-1.1591219E7|-1.0999782E7|-0.35|CAPR|186|
|CAPR.O|Capricor|2024 Q3|-1.300988E7|-1.2556728E7|-0.38|CAPR|186|

In conclusion, the combination of a bearish trend, analyst expectations, recent price action, and financial health indicators suggest that CAPR may continue to decline further in the absence of positive news or changes in investor sentiment.